Bilal Bham graduated from the University of Manchester with a BSc in Genetics (2.1 hons), and an MSc in Immunology and Immunogenetics, completing placements with European Molecular Biology Laboratories (EMBL) and the European Molecular Biology Organisation (EMBO) Report during his studies. Whilst at EMBO, an article he published in the Science and Society Section sparked his interest in and creative flair for scientific writing.
Renovo’s liquidation gave Bilal the opportunity to become a freelance medical writer, the success of which led to the launch of Bham Pharma Ltd.
Bilal’s passion for technology and flair for marketing saw him diversify the business when he realised the potential for content to engage over social media. Bham Digital Ltd was the result, bringing together the best of hard science and effective social media.
Today, the Bham Pharma and Bham Digital teams continue to deliver high quality, cost-effective content for the pharmaceutical, biotechnology, and medical devices industries, whilst looking after our talented team of specialists.